About Eisai Pharmaceuticals India Private Limited
Data last updated:
Eisai Pharmaceuticals India Private Limited is a private limited company based in Paravada, Andhra Pradesh, India, a subsidiary of Eisai Co., Ltd.. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 22 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U21002AP2007PTC053247. Its GSTIN is 27AABCE8168P1ZX (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹318 Cr and a paid-up capital of ₹270.83 Cr. It was formerly known as Eisai Pharmatechnology & Manufacturing Private Limited. It is led by directors including Shohei Kanazawa and Kentaro Nagane.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot Nos. 96 97 98 124 & 126, Visakha Pharmacity Limited (SEZ) Paravada Mandal, Andhra Pradesh, India – 531019.
As per the financials filed for FY 2025, the company reported a revenue of ₹402.38 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹58.8 Cr (net margin 14.6%) and EBITDA of ₹104.65 Cr (EBITDA margin 26%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 10% over five years.
The company has about 541 employees on its provident fund (EPFO) records.
Court records list 10 cases involving the company, including 7 filed by the company and 3 filed against it; 1 case is pending. The company has 3 deals on record (3 funding rounds), with disclosed funding of ₹270 Cr; the latest was in November 2011. The company has 16 MSME Form 1 returns on record between 2016 and 2023, listing 769 overdue payments to 78 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eisai.co.in.
Company details
CIN history
Eisai Pharmaceuticals India has one previous CIN (Corporate Identification Number): U24232AP2007PTC053247. The current CIN is U21002AP2007PTC053247, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21002AP2007PTC053247 | Current |
| U24232AP2007PTC053247 | Previous |
Contact details
Eisai Pharmaceuticals India Private Limited's registered office is in Paravada, Andhra Pradesh.
- Registered AddressPlot Nos. 96 97 98 124 & 126, Visakha Pharmacity Limited (SEZ) Paravada Mandal, Andhra Pradesh, India – 531019
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Eisai Pharmaceuticals India are manufacturing, wholesale and retail trade; repair of motor vehicles and motorcycles and professional, scientific and technical activities. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations, wholesale trade, except of motor vehicles and motorcycles and scientific research and development. 3 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | |
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | |
| M | Professional, scientific and technical activities | 72 | Scientific research and development |
To see the full business activity and turnover split of Eisai Pharmaceuticals India Private Limited, buy the company report.
Financials of Eisai Pharmaceuticals India Private Limited
FY 2025 filings availableEisai Pharmaceuticals India Private Limited reported revenue of ₹402.38 Cr (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 15% fall in the latest year. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹104.65 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹58.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26% | ||||
| Net Profit Margin | 14.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eisai Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Eisai Pharmaceuticals India Private Limited
Eisai Pharmaceuticals India has 7 current directors and 29 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shohei Kanazawa | Director | 25 Jun 2020 | 6 Years 4 Months | Current |
| Kentaro Nagane | Director | 22 Mar 2024 | 2 Years 7 Months | Current |
| Girish Dixit | Director | 24 Oct 2019 | 7 Years 0 Months | Current |
| Mitsuru Shomon | Director | 16 Sep 2021 | 5 Years 1 Months | Current |
| Akiko Nakahama | Director | 16 Jun 2025 | 1 Years 4 Months | Current |
| Masahito Suzuki | Director | 16 Jun 2025 | 1 Years 4 Months | Current |
Deals & funding
Eisai Pharmaceuticals India Private Limited has 3 deals on record (3 funding rounds), with disclosed funding of ₹270 Cr; the latest was in November 2011.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2011 | Funding round | ₹30 Cr | Investors: EISAI Asia Regional Services Pte Limited |
| Feb 2009 | Funding round | ₹120 Cr | Investors: EISAI Company Limited |
| Jun 2007 | Funding round | ₹120 Cr | Investors: EISAI Company Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Eisai Pharmaceuticals India Private Limited has 10 court cases on record: 7 filed by Eisai Pharmaceuticals India, 3 filed against it. 1 case is pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 1 | 0 |
| District courts | 2 | 2 | 1 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Patna, Bihar | Court case (Caveat) | Filed against the company by Basudeo Prsad Jaiswal.Propriter.M/S Emcure Pharmaceutiecals Limted | Pending |
| District court, Patna, Bihar | Court case (Caveat) | Filed against the company by M/S Emcure Pharmaceutical Limited Through Sanjay Kumar | Disposed |
| Bombay High Court | Court case (OLR) | Filed against the company by The Official Liquidator High Court Bombay | Disposed |
| High Court, ANDHRAPRADESH | Company petition | Filed by the company | Disposed |
| High Court, ANDHRAPRADESH | Court case (COMPA) | Filed by the company | Disposed |
To see the full case history of Eisai Pharmaceuticals India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Eisai Pharmaceuticals India Private Limited has 16 MSME Form 1 returns on record between 2016 and 2023, listing 769 overdue payments to 78 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 78)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Prince Graphics Private Limited | |||
| an individual supplier | |||
| Intech Systems Pvt Ltd | |||
| Indimax Print Private Limited |
To see the full MSME payment records of Eisai Pharmaceuticals India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Eisai Pharmaceuticals India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCE8168P1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Eisai Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Eisai Pharmaceuticals India Private Limited has 36 board changes on record since 2007: 7 appointments and 29 cessations. The latest: Takuya Kijima was appointed as Additional Director on 17 Oct 2025.
27 earlier events are in the company report.
Frequently asked questions
Eisai Pharmaceuticals India is an active private limited company based in Paravada, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 22 March 2007 (19+ years old) and is registered under CIN U21002AP2007PTC053247.
Eisai Pharmaceuticals India has 7 current directors:
- Shohei Kanazawa - Director
- Kentaro Nagane - Director
- Girish Dixit - Director
- Mitsuru Shomon - Director
- Akiko Nakahama - Director
- Masahito Suzuki - Director
- Takuya Kijima - Additional Director
The latest financial statements of Eisai Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Eisai Pharmaceuticals India is 27AABCE8168P1ZX, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Eisai Pharmaceuticals India is U21002AP2007PTC053247. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eisai Pharmaceuticals India has 10 court cases on record: 7 filed by the company and 3 filed against it. 1 is pending. Most are in the high courts.
Eisai Pharmaceuticals India was incorporated on 22 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Vijayawada.
Eisai Pharmaceuticals India has 3 deals on record (3 funding rounds), with disclosed funding of ₹270 Cr; the latest was in November 2011.
Takuya Kijima was appointed as Additional Director on 17 Oct 2025. Akiko Nakahama ceased to be Additional Director on 18 Sep 2025. Masahito Suzuki ceased to be Additional Director on 18 Sep 2025. Eisai Pharmaceuticals India has 36 board changes on record in total.
Eisai Pharmaceuticals India has 16 MSME Form 1 returns on record between 2016 and 2023, listing 769 overdue payments to 78 micro and small suppliers. The latest return was filed on 16 Dec 2023.
Eisai Pharmaceuticals India can be reached through the website eisai.co.in. Its registered office is in Paravada, Andhra Pradesh, India.